Related Experiment Videos
Isoantibodies to human serum proteins in children after blood and plasma transfusions
Insights
Blood transfusions can influence antibody formation in children. This study found evidence of altered immune responses following blood and blood-product therapies in pediatric patients, highlighting potential impacts on antibody development.
Area of Science:
- Immunology
- Pediatric Medicine
- Transfusion Medicine
Background:
- Blood and blood-product transfusions are common in pediatric care.
- Serologic incompatibility and various blood diseases necessitate transfusion therapies.
- The potential for transfusions to induce immune responses, including antibody formation, requires investigation.
Purpose of the Study:
- To investigate the influence of blood and blood-product therapy on antibody formation in children.
- To identify specific types of antibodies generated following transfusion interventions.
Main Methods:
- Study involved two groups of children: those undergoing exchange transfusion and those with blood diseases receiving multiple transfusions.
- Immunoprecipitation assays were used to detect isoprecipitins and antibodies.
- Specific antibody types, including anti-Gm antibodies and antibodies to lipoprotein factors, were analyzed.
Main Results:
- In children who had exchange transfusions, isoprecipitins were detected in 7 cases, with some reacting to lipoprotein factors and one showing anti-Gm 2 antibodies.
- In children with blood diseases receiving multiple transfusions, 38% developed precipitins, including antibodies to lipoprotein factors, but no anti-Gm antibodies were found.
- The findings suggest that transfusions can impact the development of antibodies against human proteins.
Conclusions:
- Transfusions of blood and blood products can influence the immune system's antibody production in pediatric patients.
- The study demonstrates a correlation between transfusion therapy and the emergence of specific antibodies, particularly against lipoprotein factors.
- Further research is warranted to fully understand the long-term immunological consequences of transfusion interventions in children.
Abstract:
The influence of blood and blood-product therapy was studied in two groups of children: 1) 90 children who had exchange transfusion after birth because of serologic incompatibility (aged 5 months to 5 years). In 7 children of this group isoprecipitins were detected. In 4 cases they reacted probably with lipoprotein group factors. One child had anti-Gm 2 antibodies. 2) 32 patients with various blood diseases, aged 18 months to 17 years, who had multiple transfusions of blood or plasma. In 12 children of this group (38%), precipitins were demonstrated. Two had antibodies to lipoprotein group factors. No anti-Gm antibodies were discovered in this group of children. The results of the study indicate an influence of transfusions of blood and blood products on the formation of antibodies to human proteins.